| Pharmaceutical active ingredients: |
| CinnarizineHeptaminol Acefyllinate |
| Available forms, composition and doses of Sureptil: |
| Tablets; Oral; Cinnarizine 20 mg; Heptaminol Acefyllinate 200 mg |
| Sureptil medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DX08 - HeptaminolN07CA52 - Cinnarizine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisDelalande Isnardi Laboratori |